Zimmer Biomet (ZBH) announced the U.S. FDA has granted Breakthrough Device Designation for the company’s first-to-world iodine-treated total hip replacement system. This is the first product in Zimmer Biomet history to receive this designation.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZBH:
- Zimmer Biomet: FDA grants BDD for treated total hip replacement system
- Zimmer Biomet’s Knee System Study: A Potential Game-Changer in Orthopedics
- Zimmer Biomet’s Knee Implant Study: A Market Game-Changer?
- Zimmer Biomet’s Persona Revision Knee System Study: A Market Game-Changer?
- Zimmer Biomet’s Latest Clinical Study: A Potential Game-Changer in Hip Arthroplasty